305 related articles for article (PubMed ID: 17906636)
41. The role of mast cell and mast cell subtypes (MC(T) and MC(CT)) in tumor angiogenesis.
Ozdemir O
Eur J Cardiothorac Surg; 2006 Apr; 29(4):638-9; author reply 639. PubMed ID: 16495065
[No Abstract] [Full Text] [Related]
42. Can a mast cell subtype (MC(T)) play a role in the progression of endometrial cancer through angiogenesis?
Ozdemir O
Am J Obstet Gynecol; 2006 Dec; 195(6):e24; author reply e25. PubMed ID: 16677596
[No Abstract] [Full Text] [Related]
43. Although Abundant in Tumor Tissue, Mast Cells Have No Effect on Immunological Micro-milieu or Growth of HPV-Induced or Transplanted Tumors.
Ghouse SM; Polikarpova A; Muhandes L; Dudeck J; Tantcheva-Poór I; Hartmann K; Lesche M; Dahl A; Eming S; Müller W; Behrendt R; Roers A
Cell Rep; 2018 Jan; 22(1):27-35. PubMed ID: 29298428
[TBL] [Abstract][Full Text] [Related]
44. Evaluating tumor angiogenesis.
Uh MK; Kandel J; Kitajewski J
Methods Mol Biol; 2013; 980():341-51. PubMed ID: 23359165
[TBL] [Abstract][Full Text] [Related]
45. Mast cell density, neoplastic angiogenesis and their prognostic importance.
Ozdemir O
Dig Liver Dis; 2006 May; 38(5):356. PubMed ID: 16413838
[No Abstract] [Full Text] [Related]
46. Might mast cells have a role in neoplastic angiogenesis of canine melanomas?
Ozdemir O
Vet Dermatol; 2006 Aug; 17(4):284-6; discussion 289. PubMed ID: 16827673
[No Abstract] [Full Text] [Related]
47. Tumor microenvironment: becoming sick of Myc.
Whitfield JR; Soucek L
Cell Mol Life Sci; 2012 Mar; 69(6):931-4. PubMed ID: 22033838
[TBL] [Abstract][Full Text] [Related]
48. Mast cells and the tumor-associated neoangiogenesis.
Ozdemir O
Med Sci Monit; 2006 Jun; 12(6):LE9-11. PubMed ID: 16733492
[No Abstract] [Full Text] [Related]
49. Mast cell infiltration and obesity-related glomerulopathy: an under-recognized disease process and new ways to approach treatment.
Naljayan M; Reisin E
Curr Hypertens Rep; 2014 Oct; 16(10):480. PubMed ID: 25164964
[No Abstract] [Full Text] [Related]
50. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.
Huang B; Lei Z; Zhang GM; Li D; Song C; Li B; Liu Y; Yuan Y; Unkeless J; Xiong H; Feng ZH
Blood; 2008 Aug; 112(4):1269-79. PubMed ID: 18524989
[TBL] [Abstract][Full Text] [Related]
51. Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.
Strouch MJ; Cheon EC; Salabat MR; Krantz SB; Gounaris E; Melstrom LG; Dangi-Garimella S; Wang E; Munshi HG; Khazaie K; Bentrem DJ
Clin Cancer Res; 2010 Apr; 16(8):2257-65. PubMed ID: 20371681
[TBL] [Abstract][Full Text] [Related]
52. Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.
Ali K; Soond DR; Pineiro R; Hagemann T; Pearce W; Lim EL; Bouabe H; Scudamore CL; Hancox T; Maecker H; Friedman L; Turner M; Okkenhaug K; Vanhaesebroeck B
Nature; 2014 Jun; 510(7505):407-411. PubMed ID: 24919154
[TBL] [Abstract][Full Text] [Related]
53. Mast cells play a protumorigenic role in primary cutaneous lymphoma.
Rabenhorst A; Schlaak M; Heukamp LC; Förster A; Theurich S; von Bergwelt-Baildon M; Büttner R; Kurschat P; Mauch C; Roers A; Hartmann K
Blood; 2012 Sep; 120(10):2042-54. PubMed ID: 22837530
[TBL] [Abstract][Full Text] [Related]
54. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.
Purwar R; Schlapbach C; Xiao S; Kang HS; Elyaman W; Jiang X; Jetten AM; Khoury SJ; Fuhlbrigge RC; Kuchroo VK; Clark RA; Kupper TS
Nat Med; 2012 Aug; 18(8):1248-53. PubMed ID: 22772464
[TBL] [Abstract][Full Text] [Related]
55. Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity.
Saleem SJ; Martin RK; Morales JK; Sturgill JL; Gibb DR; Graham L; Bear HD; Manjili MH; Ryan JJ; Conrad DH
J Immunol; 2012 Jul; 189(2):511-5. PubMed ID: 22706087
[TBL] [Abstract][Full Text] [Related]
56. Mast cells impair the development of protective anti-tumor immunity.
Wasiuk A; Dalton DK; Schpero WL; Stan RV; Conejo-Garcia JR; Noelle RJ
Cancer Immunol Immunother; 2012 Dec; 61(12):2273-82. PubMed ID: 22684520
[TBL] [Abstract][Full Text] [Related]
57. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer.
Hu B; Elinav E; Huber S; Strowig T; Hao L; Hafemann A; Jin C; Wunderlich C; Wunderlich T; Eisenbarth SC; Flavell RA
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9862-7. PubMed ID: 23696660
[TBL] [Abstract][Full Text] [Related]
58. Mast cells are an essential hematopoietic component for polyp development.
Gounaris E; Erdman SE; Restaino C; Gurish MF; Friend DS; Gounari F; Lee DM; Zhang G; Glickman JN; Shin K; Rao VP; Poutahidis T; Weissleder R; McNagny KM; Khazaie K
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19977-82. PubMed ID: 18077429
[TBL] [Abstract][Full Text] [Related]
59. Endogenous Myc maintains the tumor microenvironment.
Sodir NM; Swigart LB; Karnezis AN; Hanahan D; Evan GI; Soucek L
Genes Dev; 2011 May; 25(9):907-16. PubMed ID: 21478273
[TBL] [Abstract][Full Text] [Related]
60. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Jansen CS; Prokhnevska N; Master VA; Sanda MG; Carlisle JW; Bilen MA; Cardenas M; Wilkinson S; Lake R; Sowalsky AG; Valanparambil RM; Hudson WH; McGuire D; Melnick K; Khan AI; Kim K; Chang YM; Kim A; Filson CP; Alemozaffar M; Osunkoya AO; Mullane P; Ellis C; Akondy R; Im SJ; Kamphorst AO; Reyes A; Liu Y; Kissick H
Nature; 2019 Dec; 576(7787):465-470. PubMed ID: 31827286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
